Scientists: mRNA Vaccine Research Cuts Blow to Innovation
Briefly

Concerns arise over the government's decision to halt investments in mRNA vaccine development, a technology pivotal in COVID-19 vaccine creation. The discontinuation, led by the Department of Health and Human Services, includes canceling $500 million in contracts with biotech firms. Critics warn that this move undermines the U.S.'s role in biomedical research. Experts assert mRNA technology shows promise for various diseases and emphasize its misunderstood benefits, stating its potential could revolutionize medicine in the future and has already saved millions of lives.
"We reviewed the science, listened to the experts, and acted," Kennedy said, claiming that "the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu."
Jeff Coller stated, "mRNA technology is incredibly misunderstood by the public and many of our politicians." He emphasized that "the science has always been consistently clear about the powerful medical benefits of the mRNA platform."
Read at Inside Higher Ed | Higher Education News, Events and Jobs
[
|
]